Individualized Adaptive De-escalated Radiotherapy for HPV-related Oropharynx Cancer

Condition:   Oropharynx Cancer
Interventions:   Drug: Cetuximab;   Radiation: Radiation Therapy
Sponsors:   University of Michigan Cancer Center;   VA Ann Arbor Healthcare System
Not yet recruiting

http://ift.tt/2DNxFJV